Renishaw to create diagnostics with fellow U.K. firm

10/3/2013 | Genetic Engineering & Biotechnology News

MRC Technology and Renishaw Diagnostics will work together to identify and design new diagnostic tests for infectious diseases with the help of Renishaw's RenDx multiplex assay technology. RenDx provides automated, high-sensitivity and in vitro detection of as many as nine targets in one sample.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI